Athenex Presents Interim Data from Oral Paclitaxel Phase II Study in Cutaneous Angiosarcoma at ASCO20 Virtual Scientific Program

NEXT STORY
CytomX Therapeutics Clinical Programs Highlighted at American Society of Clinical Oncology ASCO20 Virtual Scientific Program
PREV STORY
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ASCO20 Virtual Scientific Program
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Assurance Health and Wellness of Tucson Acquires Arizona Counseling and Treatment Services

TUCSON, Ariz., April 27, 2016 (GLOBE NEWSWIRE) -- Tucson-based Sinfonía HealthCare Corporation today announced ...

author_avatar
NASDAQ Market News

GeoVax’s Chief Scientific Officer to Speak at World Vaccine Congress

GeoVax Also Nominated for Vaccine Industry Excellence Awards Atlanta, GA, March 26, 2018 (GLOBE ...

author_avatar
NASDAQ Market News

Celldex Reports Third Quarter 2016 Results

HAMPTON, N.J., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported ...

author_avatar
NASDAQ Market News